BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15996083)

  • 1. Refractory polyarteritis nodosa successfully treated with infliximab.
    Al-Bishri J; le Riche N; Pope JE
    J Rheumatol; 2005 Jul; 32(7):1371-3. PubMed ID: 15996083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid healing of chronic leg ulcers during perilesional injections of granulocyte-macrophage colony-stimulating factor therapy in a patient with cutaneous polyarteritis nodosa.
    Tursen U; Api H; Kaya TI; Cinel L; Ikizoglu G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1341-3. PubMed ID: 17062064
    [No Abstract]   [Full Text] [Related]  

  • 3. Iloprost in the management of leg ulcer in polyarteritis nodosa. A case report.
    Biancari F; Kantonen I; Peltomaa R; Lepäntalo M
    Int Angiol; 1999 Dec; 18(4):335-6. PubMed ID: 10811524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa.
    Kawakami T; Soma Y
    J Am Acad Dermatol; 2010 Oct; 63(4):602-6. PubMed ID: 20675014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose methotrexate controls a severe form of polyarteritis nodosa.
    Boehm I; Bauer R
    Arch Dermatol; 2000 Feb; 136(2):167-9. PubMed ID: 10677090
    [No Abstract]   [Full Text] [Related]  

  • 6. Ulcerative cutaneous polyarteritis nodosa treated with mycophenolate mofetil and pentoxifylline.
    Kluger N; Guillot B; Bessis D
    J Dermatolog Treat; 2011 Jun; 22(3):175-7. PubMed ID: 20666666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous periarteritis nodosa resistant to combined corticosteroids and immunosuppressive agents. Efficacy of treatment with intravenous immunoglobulins].
    Machet L; Vincent O; Machet MC; Barruet K; Vaillant L; Lorette G
    Ann Dermatol Venereol; 1995; 122(11-12):769-72. PubMed ID: 8729821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis.
    Garcia-Porrua C; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S138. PubMed ID: 14740443
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab in a child with therapy-resistant systemic vasculitis.
    de Kort SW; van Rossum MA; ten Cate R
    Clin Rheumatol; 2006 Sep; 25(5):769-71. PubMed ID: 16267606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous periarteritis nodosa: diagnostic and therapeutic aspects of 9 cases].
    Maillard H; Szczesniak S; Martin L; Garot D; Machet MC; Machet L; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):125-9. PubMed ID: 10352826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.
    Matsuo S; Hayashi K; Morimoto E; Kato A; Sada KE; Watanabe H; Takano-Narazaki M; Sunahori-Watanabe K; Kawabata T; Wada J
    Intern Med; 2017; 56(11):1435-1438. PubMed ID: 28566612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous polyarteritis nodosa: A rare cause of chronic ulcers].
    Jansen TM; Hoff NP
    Hautarzt; 2015 Oct; 66(10):720-2. PubMed ID: 26311032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission induced by infliximab in a childhood polyarteritis nodosa refractory to conventional immunosuppression and rituximab.
    Campanilho-Marques R; Ramos F; Canhão H; Fonseca JE
    Joint Bone Spine; 2014 May; 81(3):277-8. PubMed ID: 24388782
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute pancreatitis with pseudocyst formation in a patient with polyarteritis nodosa.
    Suresh E; Beadles W; Welsby P; Luqmani R
    J Rheumatol; 2005 Feb; 32(2):386-8. PubMed ID: 15693106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous polyarteritis nodosa.
    Kleeman D; Kempf W; Burg G; Hafner J
    Vasa; 1998 Feb; 27(1):54-7. PubMed ID: 9540436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for the treatment of refractory polyarteritis nodosa.
    Ginsberg S; Rosner I; Slobodin G; Rozenbaum M; Kaly L; Jiries N; Boulman N; Awisat A; Hussein H; Novofastovski I; Silawy A; Rimar D
    Clin Rheumatol; 2019 Oct; 38(10):2825-2833. PubMed ID: 30972576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in a patient treated for polyarteritis nodosa.
    Scatena P; Messina F; Gori S; Ruocco L; Vignali C; Menichetti F; Castiglioni M
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S121-3. PubMed ID: 14740438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous calcification presenting in a patient with mixed connective tissue disease and cutaneous polyarteritis nodosa.
    Goolamali SI; Gordon P; Salisbury J; Creamer D
    Clin Exp Dermatol; 2009 Jul; 34(5):e141-4. PubMed ID: 19508582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab.
    Vega Gutierrez J; Rodriguez Prieto MA; Garcia Ruiz JM
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):570-1. PubMed ID: 17374009
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polyarteritis nodosa diagnosed in acute cholecystectomy].
    Storr GZ; Engelhart M; Aru A
    Ugeskr Laeger; 2000 Mar; 162(10):1400-1. PubMed ID: 10745681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.